Thioredoxin-related protein 32 (TRP32) specifically reduces oxidized phosphatase of regenerating liver (PRL)

Tasuku Ishii1, Yosuke Funato, Hiroaki Miki

  • 1Department of Cellular Regulation, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.

Insights

Thioredoxin-related protein 32 (TRP32) specifically reduces PRL, a phosphatase linked to metastasis. TRP32 maintains PRL in its active, reduced state, regulating its function in cells.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cancer Research

Background:

  • The PRL (PHAS/PRL) phosphatase family is implicated in cancer metastasis.
  • PRL's catalytic cysteine undergoes reversible oxidation, inactivating its phosphatase activity.
  • Understanding PRL regulation is crucial for targeting metastasis.

Purpose of the Study:

  • To investigate the specific protein responsible for reducing oxidized PRL.
  • To elucidate the mechanism by which PRL activity is regulated.
  • To identify novel regulators of PRL function in cellular processes.

Main Methods:

  • In vitro reduction assays using purified proteins.
  • Cellular experiments involving TRP32 knockdown and H2O2 treatment.
  • Inhibition studies using 2,4-dinitro-1-chlorobenzene.
  • Protein binding analyses to identify interaction domains.

Main Results:

  • Thioredoxin-related protein 32 (TRP32) specifically and potently reduces oxidized PRL in vitro.
  • TRP32-mediated reduction of PRL is sensitive to TRX reductase inhibition.
  • TRP32 knockdown prolongs PRL oxidation induced by hydrogen peroxide.
  • The unique C-terminal domain of TRP32 is essential for direct PRL interaction.

Conclusions:

  • TRP32 functions as the primary reductase for oxidized PRL.
  • TRP32 maintains PRL in its active, reduced state.
  • TRP32-mediated regulation of PRL impacts its biological functions, potentially including metastasis.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...